{"title":"Potential Impurities of Tigecycline: Synthesis, Isolation, Characterization and In Vitro Pharmacological Evaluation","authors":"Palaniyandi Nallusamy Sharavanan Selliamman, Subramanian Chidambaram, Sathiyanarayanan Singaram, Kabilan Senthamaraikannan","doi":"10.2174/1573412915666190225160030","DOIUrl":null,"url":null,"abstract":"\n\nTigecycline is a known antibiotic in the tetracycline family and a chemical\nanalog of minocycline. It may be used for the treatment against drug-resistant bacteria.\n\n\n\n HPLC method was used for related substance analysis. The degraded impurities during the\nprocess were isolated and characterized by IR, HRMS (High Resolution Mass Spectrometry) and NMR\nspectral analysis.\n\n\n\nFour impurities of tigecycline, a broad spectrum antibacterial agent, were identified, synthesized\nand characterized. The in vitro biological evaluation of the isolated compounds showed significant\nantimicrobial and antioxidant properties to that of tigecycline. Apart from these, the tigecycline drug\nsubstance showed significant degradation under oxidation conditions.\n\n\n\nThe extensive investigational data confirm the structure of the four impurities. The specification\nlimit for these impurities is applied based on the toxicological data. The antimicrobial activity\nrevealed that the impurity 4 shows excellent activity towards both Gram-positive and Gram-negative\nbacteria when compared with tigecycline. The results obtained for DPPH (2,2-diphenyl-1-\npicrylhydrazyl) antioxidant activity concluded that the impurity 2 and the impurity 3 showed good antioxidant\nproperties when compared with tigecycline. There was no activity observed on fungi for both\nisolated degradants as well as tigecycline.\n","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmaceutical Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1573412915666190225160030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2
Abstract
Tigecycline is a known antibiotic in the tetracycline family and a chemical
analog of minocycline. It may be used for the treatment against drug-resistant bacteria.
HPLC method was used for related substance analysis. The degraded impurities during the
process were isolated and characterized by IR, HRMS (High Resolution Mass Spectrometry) and NMR
spectral analysis.
Four impurities of tigecycline, a broad spectrum antibacterial agent, were identified, synthesized
and characterized. The in vitro biological evaluation of the isolated compounds showed significant
antimicrobial and antioxidant properties to that of tigecycline. Apart from these, the tigecycline drug
substance showed significant degradation under oxidation conditions.
The extensive investigational data confirm the structure of the four impurities. The specification
limit for these impurities is applied based on the toxicological data. The antimicrobial activity
revealed that the impurity 4 shows excellent activity towards both Gram-positive and Gram-negative
bacteria when compared with tigecycline. The results obtained for DPPH (2,2-diphenyl-1-
picrylhydrazyl) antioxidant activity concluded that the impurity 2 and the impurity 3 showed good antioxidant
properties when compared with tigecycline. There was no activity observed on fungi for both
isolated degradants as well as tigecycline.
期刊介绍:
Aims & Scope
Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.